Antitumor activity of KW-2170, a novel pyrazoloacridone derivative

Anti-Cancer Drugs

Volumn 9, Issue 3, 1998, Pages 263-271

  Ashizawa, Tadashi ^a   Shimizu, Makiko ^a   Gomi, Katsushige ^a   Okabe, Masami ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Adriamycin; Antitumor; KW 2170; Mouse

Indexed keywords

5 (3 AMINOPROPYL)AMINO 7,10 DIHYDROXY 2 (2 HYDROXETHYL)AMINOETHYL 6H PYRAZOLO[4,5,1 DE]ACRIDIN 6 ONE DIHYDROCHLORIDE; ACRIDONE DERIVATIVE; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CALCIUM CHANNEL BLOCKING AGENT; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; LOSOXANTRONE; PYRAZOLONE DERIVATIVE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; TOXICITY TESTING;

EID: 0031946083     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199803000-00009     Document Type: Article

References (19)

1. Arcamore F, Cassinelli G, Fautini G, et al. Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic form S. peucetius var. caesius. Biotechnol Bioeng 1969; 11: 1101-9.
2. Carter SK. Adriamycin, a review. J Natl Cancer Inst 1975; 55: 1265-74.
3. Tsuruo T. Mechanisms of multidrug resistance and implication for therapy. Jpn J Cancer Res 1988; 79: 285-96.
4. Leopold WR, Nelson JM, Plowman J, et al. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors. Cancer Res 1985; 45: 5532-9.
5. Talbot DC, Smith IE, Mansi JL, et al. Anthrapyrazole CI-941: a highly active new agent in the treatment of advanced breast cancer. J Clin Oncol 1991; 9: 2141-7.
6. Sugaya T, Mimura Y, Shida Y, et al. 6H-pyrazolo[4,5,1-de]acridin-6-ones as a novel class of antitumor agents. Synthesis and biological activity. J Med Chem 1994; 37: 1028-32.
7. Ikeda S, Mimura Y, Nakamura A, et al. Synthesis and antitumor activity of 7,10-dihidroxy-6H-pyrazolo[4,5,1-de]acridin-6-one derivatives. In: 24th Natl Med Chem Symp Abst. Salt Lake City, UT 1994: 110.
8. Hamilton TC, Young RC, Ozols RF, et al. Experimental models systems of cancer applications to the design and evaluation of new treatment approaches. Semin Oncol 1984; 11: 285-98.
9. Shen DW, Cardarelli C, Hwang J, et al. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 1986; 261: 7762-70.
10. Greran RI, Greenberg NH, MacDonald MM, et al. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep Part III 1972; 3: 1-103.
11. Tsuruo T, Iida-Saito H, Kawabata H, et al. Characteristics of resistance to Adriamycin in human myelogenous leukemia K562 resistance to Adriamycin and in isolated clones. Jpn J Cancer Res 1986; 77: 682-92.
12. Takano H, Kohno K, Ohno M, et al. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutant of human cancer KB cells. Cancer Res 1991; 51: 3951-7.
13. Matsuo K, Kohno K, Takano H, et al. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines. Cancer Res 1990; 50: 5819-24.
14. Batist G, Tulpule A, Sinha BK, et al. Overexpression of a novel anionic glutathion transferase in multidrug-resistant human breast cancer cells. J Biol Chem 1986; 261: 15544-9.
15. Klohs WD, Steinkampf RW, Havlich MJ, et al. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists. Cancer Res 1986; 46: 4353-6.
16. Koike K, Abe T, Hisano T, et al. Overexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins. Jpn J Cancer Res 1996; 87: 765-72.
17. Cole SPC, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650-4.
18. Graham MA, Holmes J, Patterson LH, et al. Comparative free radical biochemistry of the anti-tumor agent KW-2170 and related pyrazoloacridones. Annual Report 1994.
19. Graham MA, Newell DR, Butler J, et al. The effect of the anthrapyrazole antitumor agent CI941 on rat liver microsome an cytochrome P450 reductase mediated free radical processed: inhibition of doxorubicin activation in vitro. Biochem Pharmacol 1987; 36: 3345-51.